Literature DB >> 12786792

Determination of minimal residual disease in leukaemia patients.

Dario Campana1.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12786792     DOI: 10.1046/j.1365-2141.2003.04393.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  21 in total

1.  Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Gary Dahl; Raul C Ribeiro; W Paul Bowman; Jeffrey Taub; Stanley Pounds; Bassem I Razzouk; Norman J Lacayo; Xueyuan Cao; Soheil Meshinchi; Barbara Degar; Gladstone Airewele; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; James R Downing; Wing Leung; Ching-Hon Pui; Dario Campana
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.

Authors:  Christian Flotho; Elaine Coustan-Smith; Deqing Pei; Shotaro Iwamoto; Guangchun Song; Cheng Cheng; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

3.  Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.

Authors:  Giuseppe Gaipa; Giovanni Cazzaniga; Maria Grazia Valsecchi; Renate Panzer-Grümayer; Barbara Buldini; Daniela Silvestri; Leonid Karawajew; Oscar Maglia; Richard Ratei; Alessandra Benetello; Simona Sala; Angela Schumich; Andre Schrauder; Tiziana Villa; Marinella Veltroni; Wolf-Dieter Ludwig; Valentino Conter; Martin Schrappe; Andrea Biondi; Michael N Dworzak; Giuseppe Basso
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

4.  Role of minimal residual disease evaluation in leukemia therapy.

Authors:  Dario Campana
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

Review 5.  Current Role of Genetics in Hematologic Malignancies.

Authors:  Gaurav Prakash; Anupriya Kaur; Pankaj Malhotra; Alka Khadwal; Prashant Sharma; Vikas Suri; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-16       Impact factor: 0.900

Review 6.  Minimal residual disease quantitation in acute myeloid leukemia.

Authors:  David Shook; Elaine Coustan-Smith; Raul C Ribeiro; Jeffrey E Rubnitz; Dario Campana
Journal:  Clin Lymphoma Myeloma       Date:  2009

7.  A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome.

Authors:  Elaine Coustan-Smith; Raul C Ribeiro; Patricia Stow; Yinmei Zhou; Ching-Hon Pui; Gaston K Rivera; Francisco Pedrosa; Dario Campana
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

8.  A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia.

Authors:  Christian Flotho; Elaine Coustan-Smith; Deqing Pei; Cheng Cheng; Guangchun Song; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

Review 9.  Minimal residual disease in acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 10.  Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.